The ACTIVE trial wrap up
ACTIVE trial, the Visual Abstract
The Visual Abstract for the ACTIVE trial NephJC, scheduled for Tuesday/Wednesday this week. From the Visual Abstract artist, @KidneyBea_n
This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy
This week, we will discuss an old dilemma in nephrology. To restrict or supplement the proteins? Premise: advanced CKD and dialysis.
This week, we will discuss the use of creating chimeras to induce immune tolerance and its potential to decrease or eliminate the need for immunosuppression in kidney transplant recipients.
The Visual Abstract for the ACTIVE trial NephJC, scheduled for Tuesday/Wednesday this week. From the Visual Abstract artist, @KidneyBea_n